tokens
sequence
tags
sequence
sentence_id
stringlengths
6
11
[ "METHODS", ":", "In", "a", "population", "-", "based", "study", "in", "513", "naturally", "postmenopausal", "women", "aged", "54", "-", "67", "years", ",", "we", "studied", "the", "association", "between", "self", "-", "reported", "intramuscularly", "administered", "high", "-", "dose", "estrogen", "-", "testosterone", "therapy", "(", "estradiol", "-", "and", "testosterone", "esters", ")", "and", "aortic", "atherosclerosis", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1538
[ "Aortic", "atherosclerosis", "was", "diagnosed", "by", "radiographic", "detection", "of", "calcified", "deposits", "in", "the", "abdominal", "aorta", ",", "which", "have", "been", "shown", "to", "reflect", "intima", "atherosclerosis", "." ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1539
[ "Neither", "cardiac", "vagal", "nor", "sympathetic", "tone", "was", "altered", "by", "isoproterenol", "pretreatment", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-154
[ "Hormone", "therapy", "users", "were", "compared", "with", "never", "users", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1540
[ "RESULTS", ":", "Intramuscular", "hormone", "therapy", "use", "for", "1", "year", "or", "longer", "was", "reported", "by", "25", "women", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1541
[ "In", "almost", "half", "of", "these", "women", "severe", "atherosclerosis", "of", "the", "aorta", "was", "present", "(", "n", "=", "11", ")", ",", "while", "in", "women", "without", "hormone", "use", "severe", "atherosclerosis", "of", "the", "aorta", "was", "present", "in", "less", "than", "20", "%", "(", "OR", "3", ".", "1", ";", "95", "%", "CI", ",", "1", ".", "1", "-", "8", ".", "5", ",", "adjusted", "for", "age", ",", "years", "since", "menopause", ",", "smoking", ",", "and", "body", "mass", "index", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1542
[ "The", "association", "remained", "after", "additional", "adjustment", "for", "diabetes", ",", "cholesterol", "level", ",", "systolic", "blood", "pressure", ",", "or", "alcohol", "use", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1543
[ "No", "association", "was", "found", "for", "hormone", "use", "less", "than", "1", "year", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1544
[ "CONCLUSION", ":", "Our", "results", "suggest", "that", "high", "-", "dose", "testosterone", "therapy", "may", "adversely", "affect", "atherosclerosis", "in", "postmenopausal", "women", "and", "indicate", "that", "androgen", "replacement", "in", "these", "women", "may", "not", "be", "harmless", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1545
[ "Optimising", "stroke", "prevention", "in", "non", "-", "valvular", "atrial", "fibrillation", "." ]
[ 0, 1, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1546
[ "Atrial", "fibrillation", "is", "associated", "with", "substantial", "morbidity", "and", "mortality", "." ]
[ 1, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1547
[ "Pooled", "data", "from", "trials", "comparing", "antithrombotic", "treatment", "with", "placebo", "have", "shown", "that", "warfarin", "reduces", "the", "risk", "of", "stroke", "by", "62", "%", ",", "and", "that", "aspirin", "alone", "reduces", "the", "risk", "by", "22", "%", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1548
[ "Overall", ",", "in", "high", "-", "risk", "patients", ",", "warfarin", "is", "superior", "to", "aspirin", "in", "preventing", "strokes", ",", "with", "a", "relative", "risk", "reduction", "of", "36", "%", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1549
[ "In", "isolated", "perfused", "heart", "preparations", "from", "isoproterenol", "-", "pretreated", "rats", ",", "the", "isoproterenol", "-", "induced", "maximal", "increase", "in", "left", "ventricular", "systolic", "pressure", "was", "significantly", "reduced", ",", "compared", "with", "saline", "-", "pretreated", "rats", "(", "the", "EC50", "of", "the", "isoproterenol", "-", "induced", "increase", "in", "left", "ventricular", "systolic", "pressure", "was", "enhanced", "approximately", "22", "-", "fold", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-155
[ "Ximelagatran", ",", "an", "oral", "direct", "thrombin", "inhibitor", ",", "was", "found", "to", "be", "as", "efficient", "as", "vitamin", "K", "antagonist", "drugs", "in", "the", "prevention", "of", "embolic", "events", ",", "but", "has", "been", "recently", "withdrawn", "because", "of", "abnormal", "liver", "function", "tests", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0 ]
BC5CDR-1550
[ "The", "ACTIVE", "-", "W", "(", "Atrial", "Fibrillation", "Clopidogrel", "Trial", "with", "Irbesartan", "for", "Prevention", "of", "Vascular", "Events", ")", "study", "has", "demonstrated", "that", "warfarin", "is", "superior", "to", "platelet", "therapy", "(", "clopidogrel", "plus", "aspirin", ")", "in", "the", "prevention", "af", "embolic", "events", "." ]
[ 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1551
[ "Idraparinux", ",", "a", "Factor", "Xa", "inhibitor", ",", "is", "being", "evaluated", "in", "patients", "with", "atrial", "fibrillation", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0 ]
BC5CDR-1552
[ "Angiotensin", "-", "converting", "enzyme", "inhibitors", "and", "angiotensin", "II", "receptor", "-", "blocking", "drugs", "hold", "promise", "in", "atrial", "fibrillation", "through", "cardiac", "remodelling", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 2, 0 ]
BC5CDR-1553
[ "Preliminary", "studies", "suggest", "that", "statins", "could", "interfere", "with", "the", "risk", "of", "recurrence", "after", "electrical", "cardioversion", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1554
[ "Finally", ",", "percutaneous", "methods", "for", "the", "exclusion", "of", "left", "atrial", "appendage", "are", "under", "investigation", "in", "high", "-", "risk", "patients", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1555
[ "Anti", "-", "oxidant", "effects", "of", "atorvastatin", "in", "dexamethasone", "-", "induced", "hypertension", "in", "the", "rat", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
BC5CDR-1556
[ "1", "." ]
[ 0, 0 ]
BC5CDR-1557
[ "Dexamethasone", "(", "Dex", ")", "-", "induced", "hypertension", "is", "characterized", "by", "endothelial", "dysfunction", "associated", "with", "nitric", "oxide", "(", "NO", ")", "deficiency", "and", "increased", "superoxide", "(", "O2", "-", ")", "production", "." ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1558
[ "Atorvastatin", "(", "Ato", ")", "possesses", "pleiotropic", "properties", "that", "have", "been", "reported", "to", "improve", "endothelial", "function", "through", "increased", "availability", "of", "NO", "and", "reduced", "O2", "-", "production", "in", "various", "forms", "of", "hypertension", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1559
[ "These", "results", "show", "that", "15", "-", "day", "isoproterenol", "pretreatment", "not", "only", "abolished", "but", "reversed", "bromocriptine", "-", "induced", "tachycardia", "to", "bradycardia", ",", "an", "effect", "that", "is", "mainly", "related", "to", "further", "cardiac", "beta", "-", "adrenoceptor", "desensitization", "rather", "than", "to", "impairment", "of", "autonomic", "regulation", "of", "the", "heart", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-156
[ "In", "the", "present", "study", ",", "we", "investigated", "whether", "50", "mg", "/", "kg", "per", "day", ",", "p", ".", "o", ".", ",", "Ato", "could", "prevent", "endothelial", "NO", "synthase", "(", "eNOS", ")", "downregulation", "and", "the", "increase", "in", "O2", "-", "in", "Sprague", "-", "Dawley", "(", "SD", ")", "rats", ",", "thereby", "reducing", "blood", "pressure", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1560
[ "2", "." ]
[ 0, 0 ]
BC5CDR-1561
[ "Male", "SD", "rats", "(", "n", "=", "30", ")", "were", "treated", "with", "Ato", "(", "50", "mg", "/", "kg", "per", "day", "in", "drinking", "water", ")", "or", "tap", "water", "for", "15", "days", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1562
[ "Dexamethasone", "(", "10", "microg", "/", "kg", "per", "day", ",", "s", ".", "c", ".", ")", "or", "saline", "was", "started", "after", "4", "days", "in", "Ato", "-", "treated", "and", "non", "-", "treated", "rats", "and", "continued", "for", "11", "-", "13", "days", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1563
[ "Systolic", "blood", "pressure", "(", "SBP", ")", "was", "measured", "on", "alternate", "days", "using", "the", "tail", "-", "cuff", "method", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1564
[ "Endothelial", "function", "was", "assessed", "by", "acetylcholine", "-", "induced", "vasorelaxation", "and", "phenylephrine", "-", "induced", "vasoconstriction", "in", "aortic", "segments", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1565
[ "Vascular", "eNOS", "mRNA", "was", "assessed", "by", "semi", "-", "quantitative", "reverse", "transcription", "-", "polymerase", "chain", "reaction", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1566
[ "3", "." ]
[ 0, 0 ]
BC5CDR-1567
[ "In", "rats", "treated", "with", "Dex", "alone", ",", "SBP", "was", "increased", "from", "109", "+", "/", "-", "2", "to", "133", "+", "/", "-", "2", "mmHg", "on", "Days", "4", "and", "Day", "14", ",", "respectively", "(", "P", "<", "0", ".", "001", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1568
[ "In", "the", "Ato", "+", "Dex", "group", ",", "SBP", "was", "increased", "from", "113", "+", "/", "-", "2", "to", "119", "+", "/", "-", "2", "mmHg", "on", "Days", "4", "to", "14", ",", "respectively", "(", "P", "<", "0", ".", "001", ")", ",", "but", "was", "significantly", "lower", "than", "SBP", "in", "the", "group", "treated", "with", "Dex", "alone", "(", "P", "<", "0", ".", "05", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1569
[ "They", "suggest", "that", ",", "in", "normal", "conscious", "rats", ",", "the", "central", "tachycardia", "of", "bromocriptine", "appears", "to", "predominate", "and", "to", "mask", "the", "bradycardia", "of", "this", "agonist", "at", "peripheral", "dopamine", "D2", "receptors", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-157
[ "Endothelial", "-", "dependent", "relaxation", "and", "eNOS", "mRNA", "expression", "were", "greater", "in", "the", "Dex", "+", "Ato", "group", "than", "in", "the", "Dex", "only", "group", "(", "P", "<", "0", ".", "05", "and", "P", "<", "0", ".", "0001", ",", "respectively", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1570
[ "Aortic", "superoxide", "production", "was", "lower", "in", "the", "Dex", "+", "Ato", "group", "compared", "with", "the", "group", "treated", "with", "Dex", "alone", "(", "P", "<", "0", ".", "0001", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1571
[ "4", "." ]
[ 0, 0 ]
BC5CDR-1572
[ "Treatment", "with", "Ato", "improved", "endothelial", "function", ",", "reduced", "superoxide", "production", "and", "reduced", "SBP", "in", "Dex", "-", "treated", "SD", "rats", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1573
[ "Severe", "citrate", "toxicity", "complicating", "volunteer", "apheresis", "platelet", "donation", "." ]
[ 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1574
[ "We", "report", "a", "case", "of", "severe", "citrate", "toxicity", "during", "volunteer", "donor", "apheresis", "platelet", "collection", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1575
[ "The", "donor", "was", "a", "40", "-", "year", "-", "old", "female", ",", "first", "-", "time", "apheresis", "platelet", "donor", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1576
[ "Past", "medical", "history", "was", "remarkable", "for", "hypertension", ",", "hyperlipidemia", ",", "and", "depression", "." ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 0 ]
BC5CDR-1577
[ "Reported", "medications", "included", "bumetanide", ",", "pravastatin", ",", "and", "paroxetine", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1578
[ "Thirty", "minutes", "from", "the", "start", "of", "the", "procedure", ",", "the", "donor", "noted", "tingling", "around", "the", "mouth", ",", "hands", ",", "and", "feet", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1579
[ "A", "developmental", "analysis", "of", "clonidine", "'", "s", "effects", "on", "cardiac", "rate", "and", "ultrasound", "production", "in", "infant", "rats", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-158
[ "She", "then", "very", "rapidly", "developed", "acute", "onset", "of", "severe", "facial", "and", "extremity", "tetany", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1580
[ "Empirical", "treatment", "with", "intravenous", "calcium", "gluconate", "was", "initiated", ",", "and", "muscle", "contractions", "slowly", "subsided", "over", "approximately", "10", "to", "15", "minutes", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1581
[ "The", "events", "are", "consistent", "with", "a", "severe", "reaction", "to", "calcium", "chelation", "by", "sodium", "citrate", "anticoagulant", "resulting", "in", "symptomatic", "systemic", "hypocalcemia", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1582
[ "Upon", "additional", "retrospective", "analysis", ",", "it", "was", "noted", "that", "bumetanide", "is", "a", "loop", "diuretic", "that", "may", "cause", "significant", "hypocalcemia", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1583
[ "We", "conclude", "that", "careful", "screening", "for", "medications", "and", "underlying", "conditions", "predisposing", "to", "hypocalcemia", "is", "recommended", "to", "help", "prevent", "severe", "reactions", "due", "to", "citrate", "toxicity", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1584
[ "Laboratory", "measurement", "of", "pre", "-", "procedure", "serum", "calcium", "levels", "in", "selected", "donors", "may", "identify", "cases", "requiring", "heightened", "vigilance", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1585
[ "The", "case", "also", "illustrates", "the", "importance", "of", "maintaining", "preparedness", "for", "managing", "rare", "but", "serious", "reactions", "in", "volunteer", "apheresis", "blood", "donors", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1586
[ "Sirolimus", "-", "associated", "proteinuria", "and", "renal", "dysfunction", "." ]
[ 0, 0, 0, 1, 0, 1, 2, 0 ]
BC5CDR-1587
[ "Sirolimus", "is", "a", "novel", "immunosuppressant", "with", "potent", "antiproliferative", "actions", "through", "its", "ability", "to", "inhibit", "the", "raptor", "-", "containing", "mammalian", "target", "of", "rapamycin", "protein", "kinase", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1588
[ "Sirolimus", "represents", "a", "major", "therapeutic", "advance", "in", "the", "prevention", "of", "acute", "renal", "allograft", "rejection", "and", "chronic", "allograft", "nephropathy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1589
[ "Under", "controlled", "conditions", ",", "infant", "rats", "emit", "ultrasonic", "vocalizations", "during", "extreme", "cold", "exposure", "and", "after", "administration", "of", "the", "alpha", "(", "2", ")", "adrenoceptor", "agonist", ",", "clonidine", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-159
[ "Its", "role", "in", "the", "therapy", "of", "glomerulonephritis", ",", "autoimmunity", ",", "cystic", "renal", "diseases", "and", "renal", "cancer", "is", "under", "investigation", "." ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 2, 2, 0, 1, 2, 0, 0, 0, 0 ]
BC5CDR-1590
[ "Because", "sirolimus", "does", "not", "share", "the", "vasomotor", "renal", "adverse", "effects", "exhibited", "by", "calcineurin", "inhibitors", ",", "it", "has", "been", "designated", "a", "'", "non", "-", "nephrotoxic", "drug", "'", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
BC5CDR-1591
[ "However", ",", "clinical", "reports", "suggest", "that", ",", "under", "some", "circumstances", ",", "sirolimus", "is", "associated", "with", "proteinuria", "and", "acute", "renal", "dysfunction", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 2, 2, 0 ]
BC5CDR-1592
[ "A", "common", "risk", "factor", "appears", "to", "be", "presence", "of", "pre", "-", "existing", "chronic", "renal", "damage", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0 ]
BC5CDR-1593
[ "The", "mechanisms", "of", "sirolimus", "-", "associated", "proteinuria", "are", "multifactorial", "and", "may", "be", "due", "to", "an", "increase", "in", "glomerular", "capillary", "pressure", "following", "calcineurin", "inhibitor", "withdrawal", "." ]
[ 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1594
[ "It", "has", "also", "been", "suggested", "that", "sirolimus", "directly", "causes", "increased", "glomerular", "permeability", "/", "injury", ",", "but", "evidence", "for", "this", "mechanism", "is", "currently", "inconclusive", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1595
[ "The", "acute", "renal", "dysfunction", "associated", "with", "sirolimus", "(", "such", "as", "in", "delayed", "graft", "function", ")", "may", "be", "due", "to", "suppression", "of", "compensatory", "renal", "cell", "proliferation", "and", "survival", "/", "repair", "processes", "." ]
[ 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1596
[ "Although", "these", "adverse", "effects", "occur", "in", "some", "patients", ",", "their", "occurrence", "could", "be", "minimised", "by", "knowledge", "of", "the", "molecular", "effects", "of", "sirolimus", "on", "the", "kidney", ",", "the", "use", "of", "sirolimus", "in", "appropriate", "patient", "populations", ",", "close", "monitoring", "of", "proteinuria", "and", "renal", "function", ",", "use", "of", "angiotensin", "-", "converting", "enzyme", "inhibitors", "or", "angiotensin", "II", "receptor", "blockers", "if", "proteinuria", "occurs", "and", "withdrawal", "if", "needed", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1597
[ "Further", "long", "-", "term", "analysis", "of", "renal", "allograft", "studies", "using", "sirolimus", "as", "de", "novo", "immunosuppression", "along", "with", "clinical", "and", "laboratory", "studies", "will", "refine", "these", "issues", "in", "the", "future", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1598
[ "Proteinuria", "after", "conversion", "to", "sirolimus", "in", "renal", "transplant", "recipients", "." ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1599
[ "Picloxydine", "irrigations", "appeared", "to", "have", "a", "lower", "incidence", "of", "erosive", "cystitis", "but", "further", "studies", "would", "have", "to", "be", "performed", "before", "it", "could", "be", "recommended", "for", "use", "in", "urological", "procedures", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-16
[ "Previous", "investigations", "have", "determined", "that", ",", "in", "response", "to", "clonidine", ",", "ultrasound", "production", "increases", "through", "the", "2nd", "-", "week", "postpartum", "and", "decreases", "thereafter", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-160
[ "Sirolimus", "(", "SRL", ")", "is", "a", "new", ",", "potent", "immunosuppressive", "agent", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1600
[ "More", "recently", ",", "proteinuria", "has", "been", "reported", "as", "a", "consequence", "of", "sirolimus", "therapy", ",", "although", "the", "mechanism", "has", "remained", "unclear", "." ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1601
[ "We", "retrospectively", "examined", "the", "records", "of", "25", "renal", "transplant", "patients", ",", "who", "developed", "or", "displayed", "increased", "proteinuria", "after", "SRL", "conversion", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0 ]
BC5CDR-1602
[ "The", "patient", "cohort", "(", "14", "men", ",", "11", "women", ")", "was", "treated", "with", "SRL", "as", "conversion", "therapy", ",", "due", "to", "chronic", "allograft", "nephropathy", "(", "CAN", ")", "(", "n", "=", "15", ")", "neoplasia", "(", "n", "=", "8", ")", ";", "Kaposi", "'", "s", "sarcoma", ",", "Four", "skin", "cancers", ",", "One", "intestinal", "tumors", ",", "One", "renal", "cell", "carsinom", ")", "or", "BK", "virus", "nephropathy", "(", "n", "=", "2", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 0, 0, 1, 2, 0, 0, 1, 2, 0, 0, 1, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1603
[ "SRL", "was", "started", "at", "a", "mean", "of", "78", "+", "/", "-", "42", "(", "15", "to", "163", ")", "months", "after", "transplantation", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1604
[ "Mean", "follow", "-", "up", "on", "SRL", "therapy", "was", "20", "+", "/", "-", "12", "(", "6", "to", "43", ")", "months", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1605
[ "Proteinuria", "increased", "from", "0", ".", "445", "(", "0", "to", "1", ".", "5", ")", "g", "/", "d", "before", "conversion", "to", "3", ".", "2", "g", "/", "dL", "(", "0", ".", "2", "to", "12", ")", "after", "conversion", "(", "P", "=", "0", ".", "001", ")", "." ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1606
[ "Before", "conversion", "8", "(", "32", "%", ")", "patients", "had", "no", "proteinuria", ",", "whereas", "afterwards", "all", "patients", "had", "proteinuria", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 0 ]
BC5CDR-1607
[ "In", "28", "%", "of", "patients", "proteinuria", "remained", "unchanged", ",", "whereas", "it", "increased", "in", "68", "%", "of", "patients", "." ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1608
[ "In", "40", "%", "it", "increased", "by", "more", "than", "100", "%", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1609
[ "Given", "that", "sympathetic", "neural", "dominance", "exhibits", "a", "similar", "developmental", "pattern", ",", "and", "given", "that", "clonidine", "induces", "sympathetic", "withdrawal", "and", "bradycardia", ",", "we", "hypothesized", "that", "clonidine", "'", "s", "developmental", "effects", "on", "cardiac", "rate", "and", "ultrasound", "production", "would", "mirror", "each", "other", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-161
[ "Twenty", "-", "eight", "percent", "of", "patients", "showed", "increased", "proteinuria", "to", "the", "nephrotic", "range", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 1, 0, 0 ]
BC5CDR-1610
[ "Biopsies", "performed", "in", "five", "patients", "revealed", "new", "pathological", "changes", ":", "One", "membranoproliferative", "glomerulopathy", "and", "interstitial", "nephritis", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 1, 2, 0 ]
BC5CDR-1611
[ "These", "patients", "showed", "persistently", "good", "graft", "function", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1612
[ "Serum", "creatinine", "values", "did", "not", "change", "significantly", ":", "1", ".", "98", "+", "/", "-", "0", ".", "8", "mg", "/", "dL", "before", "SRL", "therapy", "and", "2", ".", "53", "+", "/", "-", "1", ".", "9", "mg", "/", "dL", "at", "last", "follow", "-", "up", "(", "P", "=", ".", "14", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1613
[ "Five", "grafts", "were", "lost", "and", "the", "patients", "returned", "to", "dialysis", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1614
[ "Five", "patients", "displayed", "CAN", "and", "Kaposi", "'", "s", "sarcoma", "." ]
[ 0, 0, 0, 1, 0, 1, 2, 2, 2, 0 ]
BC5CDR-1615
[ "Mean", "urinary", "protein", "of", "patients", "who", "returned", "to", "dialysis", "was", "1", ".", "26", "(", "0", ".", "5", "to", "3", ".", "5", ")", "g", "/", "d", "before", "and", "4", ".", "7", "(", "3", "to", "12", ")", "g", "/", "d", "after", "conversion", "(", "P", "=", ".", "01", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1616
[ "Mean", "serum", "creatinine", "level", "before", "conversion", "was", "2", ".", "21", "mg", "/", "dL", "and", "thereafter", ",", "4", ".", "93", "mg", "/", "dL", "(", "P", "=", ".", "02", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1617
[ "Heavy", "proteinuria", "was", "common", "after", "the", "use", "of", "SRL", "as", "rescue", "therapy", "for", "renal", "transplantation", "." ]
[ 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1618
[ "Therefore", ",", "conversion", "should", "be", "considered", "for", "patients", "who", "have", "not", "developed", "advanced", "CAN", "and", "proteinuria", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0 ]
BC5CDR-1619
[ "Therefore", ",", "in", "the", "present", "experiment", ",", "the", "effects", "of", "clonidine", "administration", "(", "0", ".", "5", "mg", "/", "kg", ")", "on", "cardiac", "rate", "and", "ultrasound", "production", "were", "examined", "in", "2", "-", ",", "8", "-", ",", "15", "-", ",", "and", "20", "-", "day", "-", "old", "rats", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-162
[ "The", "possibility", "of", "de", "novo", "glomerular", "pathology", "under", "SRL", "treatment", "requires", "further", "investigation", "by", "renal", "biopsy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1620
[ "Long", "-", "term", "follow", "-", "up", "of", "ifosfamide", "renal", "toxicity", "in", "children", "treated", "for", "malignant", "mesenchymal", "tumors", ":", "an", "International", "Society", "of", "Pediatric", "Oncology", "report", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1621
[ "The", "renal", "function", "of", "74", "children", "with", "malignant", "mesenchymal", "tumors", "in", "complete", "remission", "and", "who", "have", "received", "the", "same", "ifosfamide", "chemotherapy", "protocol", "(", "International", "Society", "of", "Pediatric", "Oncology", "Malignant", "Mesenchymal", "Tumor", "Study", "84", "[", "SIOP", "MMT", "84", "]", ")", "were", "studied", "1", "year", "after", "the", "completion", "of", "treatment", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1622
[ "Total", "cumulative", "doses", "were", "36", "or", "60", "g", "/", "m2", "of", "ifosfamide", "(", "six", "or", "10", "cycles", "of", "ifosfamide", ",", "vincristine", ",", "and", "dactinomycin", "[", "IVA", "]", ")", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1623
[ "None", "of", "them", "had", "received", "cisplatin", "chemotherapy", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1624
[ "Ages", "ranged", "from", "4", "months", "to", "17", "years", ";", "58", "patients", "were", "males", "and", "42", "females", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1625
[ "The", "most", "common", "primary", "tumor", "site", "was", "the", "head", "and", "neck", "." ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1626
[ "Renal", "function", "was", "investigated", "by", "measuring", "plasma", "and", "urinary", "electrolytes", ",", "glucosuria", ",", "proteinuria", ",", "aminoaciduria", ",", "urinary", "pH", ",", "osmolarity", ",", "creatinine", "clearance", ",", "phosphate", "tubular", "reabsorption", ",", "beta", "2", "microglobulinuria", ",", "and", "lysozymuria", "." ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
BC5CDR-1627